Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Shuwen Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6180-9565; OpenAlex author ID A5041433702. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 6

  1. Single-cell RNA-seq and spatial transcriptomics characterize CD8+ exhausted T cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2026.116934↗
  2. Trace elements in pancreatic cancer. Last author DOI 10.1002/cam4.7454↗
  3. ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis. Co-author DOI 10.3389/fmolb.2021.764900↗
  4. Analysis of T lymphocyte-related biomarkers in pancreatic cancer. Last author DOI 10.1016/j.pan.2020.09.005↗
  5. Small Nucleolar RNA and Small Nucleolar RNA Host Gene Signatures as Biomarkers for Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-42719/v1↗
  6. Identification of novel biomarkers and prognostic value of the location (head, body, or tail) of pancreatic cancer Co-author DOI 10.21203/rs.2.14728/v1↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yao Yanjun · 2 shared papers, 2024–2026 · strength 0.49
  2. Jing Mao · 1 shared paper, 2026 · strength 0.26
  3. Qiang Yan · 1 shared paper, 2026 · strength 0.26
  4. Xiaoyu Dai · 1 shared paper, 2020 · strength 0.15
  5. Xi Yang · 1 shared paper, 2020 · strength 0.13
  6. Jin Liu · 1 shared paper, 2019 · strength 0.12
  7. Chenming Ni · 1 shared paper, 2021 · strength 0.12
  8. Zhe Yang · 1 shared paper, 2021 · strength 0.12
  9. Xu Dong Sun · 1 shared paper, 2021 · strength 0.12
  10. Qiang Yan · 1 shared paper, 2021 · strength 0.12
  11. Weilin Wang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.